These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 6645780)
1. The measurement of free nitrendipine in human serum by an equilibrium dialysis - radioreceptor assay. Lee HR; Roeske WR; Yamamura HI Life Sci; 1983 Oct; 33(18):1821-9. PubMed ID: 6645780 [TBL] [Abstract][Full Text] [Related]
2. Radioreceptor and high-performance liquid chromatographic assays for the calcium channel antagonist nitrendipine in serum. Janis RA; Krol GJ; Noe AJ; Pan M J Clin Pharmacol; 1983 Jul; 23(7):266-73. PubMed ID: 6886028 [TBL] [Abstract][Full Text] [Related]
3. Sensitive radioreceptor assay of the calcium antagonist benidipine hydrochloride in plasma and urine. Ishii A; Nishida K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1733-7. PubMed ID: 3219150 [TBL] [Abstract][Full Text] [Related]
4. A simple sensitive radioreceptor assay for calcium antagonist drugs. Gould RJ; Murphy KM; Snyder SH Life Sci; 1983 Dec; 33(26):2665-72. PubMed ID: 6319847 [TBL] [Abstract][Full Text] [Related]
5. Slow dissociation of the new slow-onset and long-acting calcium antagonist benidipine hydrochloride from 3H-nitrendipine binding sites. Ishii A; Nishida K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1681-3. PubMed ID: 3219140 [TBL] [Abstract][Full Text] [Related]
6. Improved radioreceptor assay for the determination of plasma levels of dihydropyridine calcium channel blockers in humans. Quennedey MC; Ehrhardt JD; Welsch M; Rouot B; Schwartz J Ther Drug Monit; 1989 Sep; 11(5):598-606. PubMed ID: 2530665 [TBL] [Abstract][Full Text] [Related]
7. The mechanism of binding of dihydropyridine calcium channel blockers to rat brain membranes. Weiland GA; Oswald RE J Biol Chem; 1985 Jul; 260(14):8456-64. PubMed ID: 3159733 [TBL] [Abstract][Full Text] [Related]
8. Identification of calcium-channel receptors in intact animals. Roeske WR; Lee HR; Yamamura HI; Schoemaker H Adv Myocardiol; 1985; 6():71-82. PubMed ID: 2986265 [TBL] [Abstract][Full Text] [Related]
9. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers. Campbell KP; Sharp A; Strom M; Kahl SD Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317 [TBL] [Abstract][Full Text] [Related]
10. A calcium antagonist drug binding site in skeletal muscle sarcoplasmic reticulum: evidence for a calcium channel. Fairhurst AS; Thayer SA; Colker JE; Beatty DA Life Sci; 1983 Mar; 32(12):1331-9. PubMed ID: 6300579 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of 3H-nitrendipine binding in rat aortic and cerebral cortex membranes by the new dihydropyridine calcium antagonist benidipine hydrochloride. Ishii A Arzneimittelforschung; 1989 Dec; 39(12):1546-50. PubMed ID: 2624603 [TBL] [Abstract][Full Text] [Related]
12. Determination of a novel calcium channel antagonist, mepirodipine, in plasma by radioreceptor assay using (+)-[3H]PN 200-110. Yamada S; Matsuoka Y; Suzuki N; Sugimoto N; Kato Y; Kimura R Pharm Res; 1992 Sep; 9(9):1227-30. PubMed ID: 1329069 [No Abstract] [Full Text] [Related]
13. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes. Boles RG; Yamamura HI; Schoemaker H; Roeske WR J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261 [TBL] [Abstract][Full Text] [Related]
14. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A. Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884 [TBL] [Abstract][Full Text] [Related]
15. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats. Ehlert FJ; Roeske WR; Itoga E; Yamamura HI Life Sci; 1982 Jun; 30(25):2191-202. PubMed ID: 7109844 [TBL] [Abstract][Full Text] [Related]
16. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart. Lee HR; Roeske WR; Yamamura HI Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927 [TBL] [Abstract][Full Text] [Related]
17. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393 [TBL] [Abstract][Full Text] [Related]
18. Plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man and dog. Niwa T; Tokuma Y; Noguchi H Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):75-88. PubMed ID: 3563108 [TBL] [Abstract][Full Text] [Related]
19. A radioreceptor assay for determination of nicardipine in human serum using 3H(+)PN 200-110 as radioligand. Gerbeau C; Barradas J J Immunoassay; 1990; 11(3):271-94. PubMed ID: 2172306 [TBL] [Abstract][Full Text] [Related]
20. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes. Williams LT; Tremble P J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]